Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Reducing the risk of GI bleeding with antithrombotic drugs

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 29.01.20
Views: 118

Prof Andrew Chan - Harvard Medical School, Boston, USA

Prof Andrew Chan speaks to ecancer at the International Aspirin Foundation Scientific Conference 2019 in Rome about the use of antithrombotic drugs to reduce the risk of gastrointestinal (GI) bleeding.

He discusses the current development of risk scores that aim to identify patients who are at high risk of GI bleeding.

Prof Chan emphasises that it is important to convey the preventative effects of aspirin versus the side effects to patients to help them make an informed decision.

He also believes there is good evidence to suggest the use of additional medications alongside aspirin to reduce the risk of bleeding, particularly in the high-risk population.

Read more on the highlights from the 2019 International Aspirin Foundation Scientific Conference here.

Related videos

follow us

SIOG metastatic renal cell carcinoma

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation